Vanda Pharmaceuticals develops and commercializes several prescription medications focused primarily on central nervous system disorders. Its leading commercial products include Fanapt (iloperidone) for the treatment of schizophrenia and Hetlioz (tasimelteon) for non-24-hour sleep-wake disorder and nighttime sleep disturbances associated with Smith-Magenis syndrome.